Navigation Links
Watson Confirms Vyvanse® Patent Challenge
Date:7/7/2011

PARSIPPANY, N.J., July 7, 2011 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market lisdexamfetamine dimesylate capsules.  Watson's lisdexamfetamine dimesylate capsules are a generic version of Shire LLC's Vyvanse®. Vyvanse® is a prescription medicine for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children ages 6 to 17 and adults.

Shire filed suit against Watson on July 7, 2011 in the United States District Court for the Central District of California seeking to prevent Watson from commercializing its product prior to the expiration of certain U.S. Patents. Shire's lawsuit was filed under the provisions of the Hatch-Waxman Act, resulting in a stay of final FDA approval of Watson's ANDA until August 23, 2014 or until final resolution of the matter before the court, whichever occurs sooner, subject to any other exclusivities.  

For the twelve months ending April 30, 2011, Vyvanse® capsules had total U.S. sales of approximately $1.1 billion according to IMS Health data.

About Watson Pharmaceuticals, Inc.Watson Pharmaceuticals, Inc. is a leading integrated global pharmaceutical company. The Company is engaged in the development and distribution of generic pharmaceuticals and specialized branded pharmaceutical products focused on Urology and Women's Health. Watson has operations in many of the world's established and growing international markets.

For press release and other company information, visit Watson Pharmaceuticals' Web site at http://www.watson.com.

Forward-Looking Statement Statements contained in this press release that refer to non-historical facts are forwar
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Watson Launches Generic Biaxin(R) XL
2. Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder
3. Watson Announces Silodosin NDA Accepted for Filing by FDA for the Treatment of Benign Prostatic Hyperplasia
4. Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder
5. Watson Announces United States Availability of RAPAFLO(TM) (silodosin), a Novel New Treatment in Benign Prostatic Hyperplasia (BPH)
6. Watson and Barr Settle Lawsuit Over Oxytrol(R)
7. Watson to Host Conference Call and Webcast to Discuss Fourth Quarter 2009 Earnings and 2010 Outlook
8. Watson Completes Acquisition of Eden Biodesign
9. Watson to Present at Credit Suisse Healthcare Conference
10. Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy
11. Watson Files FDA Application for Generic Rozerem(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... Report Details What can be ... going to grow at the fastest rates? Visiongain,s brand ... data, trends, opportunities and prospects there. Our ... the most lucrative areas in the industry and the ... forecasted sales at overall world market and regional level. ...
(Date:9/3/2015)... YORK , Sept. 3, 2015 ... glucose device is a home-based electronic device. It ... that transmits information about glucose levels through radiowaves ... is displayed. The regular usage of self-monitoring blood ... prompt an individual to undergo proper diabetes treatment. ...
(Date:9/3/2015)... Sept. 3, 2015 About dry eye syndrome ... due to deficient tear production or quick tear evaporation ... two types: aqueous tear deficient dry eye and evaporative ... glands do not produce enough tears, whereas meibomian gland ... lipids to slow tear evaporation and maintain tear stability. ...
Breaking Medicine Technology:Ophthalmic Devices Market Forecast 2015-2025: Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 2Ophthalmic Devices Market Forecast 2015-2025: Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 3Ophthalmic Devices Market Forecast 2015-2025: Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 4Global Self-monitoring Blood Glucose Devices Market 2015-2019 2Global Dry Eye Syndrome Market 2015-2019 2
... pharmaceutical representatives won a complete victory in Federal Court ... of Joseph, Herzfeld, Hester & Kirschenbaum, Kingsley & Kingsley ... charged that plaintiffs often worked in excess of 40 ... overtime pay at the mandatory rate of time and ...
... Pharmaceutical Care Management Association (PCMA) President and ... on a new lawsuit by several drugstore lobbying groups ... payments: "California could have sidestepped this litigation ... wasteful spending by following Governor Andrew Cuomo,s (D-NY) ...
Cached Medicine Technology:Total Victory for Schering Plough Pharmaceutical Reps in National Suit for Overtime Pay 2PCMA: California Medicaid Could Save $2 Billion, Avoid Drugstore Litigation by Modernizing Medicaid Pharmacy 2
(Date:9/4/2015)... , ... September 04, 2015 , ... ... to benefit Core Compassion Project. Core Compassion Project is a non-profit organization ... to reduce the side effects of cancer treatments and recover their mobility, strength, ...
(Date:9/4/2015)... (PRWEB) , ... September 04, 2015 , ... Mike Day, ... in 2007, will compete in the Ironman World Championships in Kona on October 10th. ... have incurred Traumatic Brain Injury (TBI) through combat and the cutting-edge treatments that restore ...
(Date:9/4/2015)... ... ... Having access to a doctor can sometimes be a challenge for a ... room visits which affects hospitals’ abilities to provide quality service to those with serious ... alleviate this problem has recently presented itself, the new telemedicine platform and app, ...
(Date:9/4/2015)... ... ... Overseer at The House of Yahweh, has written an open letter to Pope Francis that ... States. , Yisrayl lays out what he says is the true meaning of the Pope’s ... the meaning of his own name and describes what bible prophecy says about his own ...
(Date:9/3/2015)... ... 2015 , ... While bariatric surgeon Michael Feiz, M.D., F.A.C.S. notes that he ... bariatric procedure, some patients have been recently asking further questions relating to the best ... types of surgery that should be followed in the days prior to the procedure, ...
Breaking Medicine News(10 mins):Health News:Girl’s Night Out to Benefit Core Compassion Project, Located at the Beautiful, Morning Glory Farm 2Health News:Navy SEAL Shot 27 Times Competes in Ironman World Championship in Kona to Raise Money for Veteran's Suffering from TBI and PTSD 2Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 2Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 3Health News:Yisrayl Hawkins Writes Open Letter to Pope Francis In Light of Approaching U.S. Visit 2Health News:Dr. Feiz and Associates Answer August's ‘Patient Submitted Question of the Month’: “How Can I Prepare for Weight Loss Surgery” 2
... ... Montgomery, Chester and Delaware Counties Go Back to School , ... Philadelphia (Vocus) June 23, 2009 -- ... Pennsylvania, will be awarding scholarships, totaling $82,000, to 41 of its members, on Tuesday, ...
... ... Foundation for its support of the Center for Cancer and Blood Disorders at Children,s National ... ... Children,s National Medical Center on Thursday honored the Children,s Cancer Foundation for its ...
... Cancer Research , a journal of the American ... may be useful in identifying patients with recurrent glioblastoma, ... endothelial growth factor therapy, specifically cediranib. Cediranib is ... (VEGF) receptor tyrosine kinases. It is an investigational, oral ...
... (June 23, 2009) -- Depression in older adults too ... worsening of medical illness, and early death. A new ... depression care manager to primary care practices can increase ... higher remission rate of depression, and reduce suicidal thoughts. ...
... License by USDA , , ROSELAND, N.J., ... leader in veterinary biologicals, today announced the availability ... (CIV), which was granted a conditional product license ... (USDA) on May 27, 2009, for ...
... Award Recognizes Entrepreneurial Excellence in Health Care Services and ... HTH Worldwide, a global health and safety services company, ... the Ernst & Young Entrepreneur Of The Year (R) ... Products category. According to Ernst & Young LLP, ...
Cached Medicine News:Health News:41 Keystone Mercy Health Plan Members to Receive Scholarships from the Plan's Employees 2Health News:Children's National Medical Center Honors The Children's Cancer Foundation for Commitment to Area Kids 2Health News:Children's National Medical Center Honors The Children's Cancer Foundation for Commitment to Area Kids 3Health News:Biomarkers predict brain tumor's response to therapy 2Health News:Biomarkers predict brain tumor's response to therapy 3Health News:Care management reduces depression and suicidal thoughts in older primary care patients 2Health News:Care management reduces depression and suicidal thoughts in older primary care patients 3Health News:New Vaccine from Intervet/Schering-Plough Animal Health is First for Canine Influenza Virus 2Health News:New Vaccine from Intervet/Schering-Plough Animal Health is First for Canine Influenza Virus 3Health News:New Vaccine from Intervet/Schering-Plough Animal Health is First for Canine Influenza Virus 4Health News:Angelo Masciantonio, CEO and Co-Founder of HTH Worldwide Named Ernst & Young 2009 Entrepreneur Of The Year(R) in Greater Philadelphia 2Health News:Angelo Masciantonio, CEO and Co-Founder of HTH Worldwide Named Ernst & Young 2009 Entrepreneur Of The Year(R) in Greater Philadelphia 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: